Key insights
- The author discusses potential value opportunities in healthcare (Tenet), fertilizer (CF Industries), and homebuilding (Toll Brothers). The core question revolves around whether seemingly cheap stocks, particularly Tenet Healthcare after an 85% run, are genuinely undervalued or if the market is pricing in future risks not yet reflected in current multiples. The analysis suggests a cautiously optimistic view, but acknowledges potential downside risks, especially for rate-sensitive sectors like homebuilding.
Tenet Healthcare is up 85% over the past year.
It still has an 11.7% earnings yield and a 12% FCF yield. PE is sitting at 15.
I've been staring at that for a few days now and I genuinely can't decide what it means.
The optimistic read is that the market spent years underpricing a healthcare operator that quietly fixed its balance sheet and improved its margins, and even after an 85% run the stock hasn't fully caught up to where it should trade.
The pessimistic read is that I'm looking at a screen that hasn't caught up to the move yet and the real opportunity was 12 months ago.
Two other names came up alongside it that I found interesting for different reasons.
CF Industries is the straightforward one. Fertilizer cycle, domestic operations, cheap on most metrics, not a lot of controversy in the setup.
Toll Brothers is the one that creates the most tension for me personally. A homebuilder showing up on a value screen in this rate environment is either genuinely interesting or a sign that the market knows something about rate sensitivity that the valuation multiples aren't capturing yet.
I keep coming back to THC though.
After an 85% move, at what point does a cheap stock stop being a value opportunity and start being a fully priced one?
That's the question I can't resolve.